4 Results for "

MAO-B active site

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "MAO-B active site" in MCE Product Catalog:

Cat. No.: HY-181141
AChE/MAO-B-IN-8 is an acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B) inhibitor with IC50 values of 0.72 and 0.19 μM. AChE/MAO-B-IN-8 interactions with AChE and MAO-B active-site amino acid residues. AChE/MAO-B-IN-8 can be used for the research of Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-187811
Research Areas:  

Neurological Disease

MAO-B-IN-62 is a MAO-B inhibitor with an IC50 of 0.8 μM against MAO-B. MAO-B-IN-62 also acts as a PPARγ agonist with an EC50 of 14.6 μM. MAO-B-IN-62 binds to the active site of free MAO-B and activates PPARγ, both with a slow dissociation rate and sustained target-binding capacity. MAO-B-IN-62 exhibits antioxidant and anti-inflammatory activities. MAO-B-IN-62 can be used in the research of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-181937
CAS No.: 3022330-81-7
Multi-target kinase-IN-10 (Compound 6l) is an orally active, blood-brain barrier-permeable, selective, reversible, and competitive MAO-B inhibitor with an IC50 of 0.0053 μM. Multi-target kinase-IN-10 competes with substrates for binding to the active site of MAO-B, chelates Cu 2+ ions, inhibits Cu 2+-induced ROS production, and reduces the release of NO, TNF-α, and IL-1β. Multi-target kinase-IN-10 ameliorates Parkinson's disease .
loading...
    loading...
Cat. No.: HY-181268
CAS No.: 3069131-62-7
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MAO-B-IN-53 is a human monoamine oxidase B (hMAO-B) inhibitor with an IC50 of 0.066 μM. MAO-B-IN-53 exhibits mixed reversible inhibition, binds stably to the hMAO-B active site, and shows high selectivity over hMAO-A. MAO-B-IN-53 acts as a neuroprotective agent, protects against 6-OHDA-induced damage, and exhibits low neurotoxicity in neuroblastoma cells. MAO-B-IN-53 can be used for the research of Parkinson's disease .
loading...
    loading...